Biostock: Iconovo inleder 2024 med order från ledande läkemedelsbolag

Iconovo har erhållit en order från ett av världens tio största läkemedelsbolag. Dessutom stärker bolaget sin CDMO-affärsmodell genom att ingå ytterligare…

Iconovo signs additional contract with Kiox Pharma for the development of a new inhalable treatment for interstitial lung disease

Iconovo has entered into an agreement to continue the formulation development with Danish rare lung disease company Kiox Pharma. This is a continuation…

Iconovo launches improved versions of nasal ICOone inhalers

Iconovo launches improved versions of nasal ICOone. Both inhalers are designed for high technical performance and to minimize the risk of user error.…

Iconovo receives order from Top-10 Pharma company for evaluation of multi-dose inhaler

Iconovo announces that it has received an order from a company revenue wise ranking among the top ten largest pharma companies in the world to evaluate…

Iconovo to participate in the regional scale-up program 10XHEALTH

Iconovo has been invited to join the 10XHEALTH program launched by SmiLe and Medicon Village. The new 10XHEALTH program aims to provide the required skills…

Iconovo recruits Gary Pitcairn (PhD) as Senior Scientific Advisor

Iconovo AB announce today that Gary Pitcairn will start working for the company in the role as Senior Scientific Advisor. Gary is a recognised expert…

Iconovos vd: ”Vi siktar på en affär för ICOpre under 2024”

Iconovos vd: ”Vi siktar på en affär för ICOpre under 2024” Året 2023 påbörjades resan för Iconovo mot att bli ett lönsamt bolag. Ett ökat…

Iconovo to present at Redeye Life Science Day November 23

Johan Wäborg, CEO, will present Iconovo at Redeye Life Science Day. Learn more about why you should invest in Iconovo and get excited by our vision to…

Busy days for Iconovo at BIO-Europe

Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation,…

Iconovo and Arcede Pharma take the next step in the development of a new treatment for COPD

Iconovo AB (publ), which develops complete inhalation products for a global market, and Arcede Pharma, which develops inhalation treatments for COPD and…